Skip to main content
Clinical Trials/NCT03431506
NCT03431506
Unknown
N/A

Vestibular Function and Vestibular Rehabilitation in Sudden Sensorneural Hearing Loss With Vertigo

Eye & ENT Hospital of Fudan University1 site in 1 country80 target enrollmentDecember 1, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Vestibular Disorder
Sponsor
Eye & ENT Hospital of Fudan University
Enrollment
80
Locations
1
Primary Endpoint
Assessment of vestibular function status by vestibular function tests in SSHL with vertigo at stage 1(before treatment)
Last Updated
8 years ago

Overview

Brief Summary

To evaluate the vestibular function and vestibular rehabilitation in sudden sensorneural hearing loss(SSHL) with vertigo

Detailed Description

Approximately 5-20 per 100,000 persons are afflicted with SSHL annually, and nearly 20-60% of SSHL patients complain of simultaneous vertigo.The aim of this study was to evaluate the prevalence of vestibulocochlear lesions in sudden sensorneural hearing loss(SSHL) with vertigo, as well as the role of vestibular rehabilitation in the prognosis of SSHL with vertigo.

Registry
clinicaltrials.gov
Start Date
December 1, 2017
End Date
December 30, 2019
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • A rapid onset sensorineural hearing loss of more than 30 dB for at least three contiguous audiometric frequencies within a period of 3 days, according to standard AAO - HNS;
  • Within 10 days from onset;
  • Without other virus infectious disease within three months.

Exclusion Criteria

  • BPPV; Meniere's disease and vestibular migraine.
  • With certain Known etiology, including acoustic neuroma, heart cerebrovascular accident, injury, Hunt syndrome, etc

Outcomes

Primary Outcomes

Assessment of vestibular function status by vestibular function tests in SSHL with vertigo at stage 1(before treatment)

Time Frame: before treatment

Vestibular function status in SSHL with vertigo at stage 1(before treatment)

Secondary Outcomes

  • Assessment of vestibular function status by vestibular function tests in SSHL with vertigo at stage 2(2 weeks after treatment)(2 weeks after treatment)
  • Assessment of vestibular function status by vestibular function tests in SSHL with vertigo at stage 2(2 months after treatment)(2 months after treatment)

Study Sites (1)

Loading locations...

Similar Trials